Even when intravenously transferred to wildtype AQP4-expressing C57Bl/6 mice, these AQP4-reactive T cells did not develop clinically meaningful behavioral manifestations or histological evidence of CNS demyelinating disease beyond meningeal inflammation (data not shown). This evidence concerns the gene AQP4 and demyelinating disease of central nervous system.